Long-term effects of octreotide therapy on in-stent restenosis
โ Scribed by S. Hurkan Kursaklioglu; Atila Iyisoy; Basri Amasyali; Cem Barcin; Sedat Kose; Turgay Celik; Ayhan Kilic; Cengiz Ozturk; Ertan Demirtas
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 196 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0910-8327
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
vein-stenosed rats without affecting the degree of mes-The hemodynamic effects of long-term administration enteric-systemic shunts. (HEPATOLOGY 1996;23:537-543.) of octreotide in portal hypertension has not been established. In addition, whether long-term octreotide treatment prevents the developmen
Procainamide is a potent inducer of autoantibodies. In order to evaluate the immunologic effects of this drug in vivo, 23 cardiac disease patients who had received procainamide for at least 6 months and an equal number of matched cardiac disease control subjects were studied, and percentage of circu
The coronary stent reduces acute coronary arterial occlusion and late restenosis during and after coronary intervention. However, stent thrombosis and restenosis are still major limitations in the widespread use of the coronary stent. Local drug delivery using the heparin-coated stent may be a new a